MATPROVIDERS MAGAZINE
Advancing the standards of Medicated Assisted Treatment for opioid use disorder through clinical insights, research, and dedicated healthcare narratives.
LATEST CLINICAL RESEARCH
Monthly Insight
How do you integrate Brixadi into your daily practice for patients with severe OUD?
Share your clinical observations and strategies for transitioning patients to long-acting buprenorphine. Selected insights will be featured in our upcoming clinical pearls column.
Advertising Opportunities
Bridge the gap between therapeutic innovation and clinical practice. Our platform delivers your message directly to healthcare providers specialized in Medicated Assisted Treatment for opioid use disorder.
15K+
MONTHLY UNIQUE PRESCRIBERS
Direct connectivity to high-volume prescribers of Suboxone and Sublocade across top-tier clinical networks.
92%
DECISION MAKER ENGAGEMENT
Our editorial focus on case studies ensures your message reaches attentive practitioners in the MAT field.
100%
CLINICAL PRACTITIONER FOCUS
Zero-waste targeting for manufacturers of Naltrexone and Brixadi. Reach only the prescribers that matter.
SUBOXONE • NALTREXONE • SUBLOCADE • BRIXADI





